| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.66B | 107.41B | 83.93B | 94.96B | 93.17B | 61.66B |
| Gross Profit | 45.55B | 36.35B | 23.67B | 26.76B | 28.18B | 17.20B |
| EBITDA | 33.85B | 24.27B | 13.94B | 17.75B | 19.77B | 10.41B |
| Net Income | 15.05B | 10.90B | 5.38B | 7.70B | 9.49B | 4.92B |
Balance Sheet | ||||||
| Total Assets | 144.65B | 127.31B | 117.71B | 112.36B | 103.76B | 79.28B |
| Cash, Cash Equivalents and Short-Term Investments | 39.64B | 27.81B | 30.64B | 25.81B | 18.87B | 17.24B |
| Total Debt | 11.78B | 11.89B | 17.20B | 18.04B | 13.59B | 9.91B |
| Total Liabilities | 46.68B | 43.19B | 45.35B | 47.44B | 45.92B | 32.44B |
| Stockholders Equity | 74.08B | 62.90B | 56.60B | 50.95B | 45.58B | 38.23B |
Cash Flow | ||||||
| Free Cash Flow | 22.34B | 6.83B | 9.46B | 7.11B | 3.36B | 4.47B |
| Operating Cash Flow | 24.36B | 8.86B | 11.88B | 8.30B | 6.30B | 6.78B |
| Investing Cash Flow | -7.19B | -3.33B | -3.19B | -1.28B | -3.01B | 1.40B |
| Financing Cash Flow | -9.19B | -7.45B | -6.11B | -379.00M | -3.51B | -2.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥163.56B | 7.03 | ― | 2.33% | 25.95% | 66.92% | |
75 Outperform | ¥755.35B | 18.30 | 9.10% | 1.63% | 6.28% | 2.62% | |
72 Outperform | ¥235.15B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
72 Outperform | ¥259.14B | 24.11 | ― | 1.17% | 29.51% | 48.81% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥112.98B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% | |
57 Neutral | ¥352.71B | 15.50 | 11.46% | 3.77% | -9.34% | 164.21% |